NCT04502589View on ClinicalTrials.gov

Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

August 11, 2021

Study Completion Date

August 11, 2021

Conditions
Alcohol Disorders
Interventions
DRUG

Perampanel Tablet

Subjects will be titrated over 3 weeks to a target dose of 8mg perampanel daily in both groups

DRUG

Disulfiram

Disulfiram will be kept at 250mg daily

Trial Locations (1)

23219

Virginia Commonwealth University Inst. for Drug and Alcohol Studies, Richmond

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Virginia Commonwealth University

OTHER

NCT04502589 - Open Label Pilot Study of Perampanel for the Treatment of Alcohol Use Disorder | Biotech Hunter | Biotech Hunter